These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 34503323)

  • 1. Asthma and COVID-19 pandemic: focus on the eosinophil count and ACE2 expression.
    Kanannejad Z; Alyasin S; Esmaeilzadeh H; Nabavizadeh H; Amin R
    Eur Ann Allergy Clin Immunol; 2022 Nov; 54(6):284-289. PubMed ID: 34503323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma Associated Cytokines Regulate the Expression of SARS-CoV-2 Receptor ACE2 in the Lung Tissue of Asthmatic Patients.
    Saheb Sharif-Askari F; Goel S; Saheb Sharif-Askari N; Hafezi S; Al Heialy S; Hachim MY; Hachim IY; Mahboub B; Salameh L; Abdelrazig M; Elzain EI; Al-Muhsen S; Al-Hajjaj MS; Ratemi E; Hamid Q; Halwani R
    Front Immunol; 2021; 12():796094. PubMed ID: 35111161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Asthma and COVID-19].
    López-Tiro JJ; Contreras-Contreras EA; Cruz-Arellanes NN; Camargo-Pirrón MA; Cabrera-Buendía EO; Ramírez-Pérez GI; Vega-Acevedo G
    Rev Alerg Mex; 2022; 69 Suppl 1():s15-s23. PubMed ID: 34998306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and Asthma: Reflection During the Pandemic.
    Liu S; Zhi Y; Ying S
    Clin Rev Allergy Immunol; 2020 Aug; 59(1):78-88. PubMed ID: 32468411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble ACE2 and TMPRSS2 Levels in the Serum of Asthmatic Patients.
    Lee JH; Lee CE; Yoo Y; Shin E; An J; Park SY; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
    J Korean Med Sci; 2022 Feb; 37(8):e65. PubMed ID: 35226423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids.
    O'Beirne SL; Salit J; Kaner RJ; Crystal RG; Strulovici-Barel Y
    Respir Res; 2021 Jul; 22(1):200. PubMed ID: 34233672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
    Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
    Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SARS-CoV-2 pandemic and asthma: What we have learned and what is still unknown.
    McPhee C; Yevdokimova K; Rogers L; Kraft M
    J Allergy Clin Immunol; 2023 Dec; 152(6):1376-1381. PubMed ID: 37739069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma and COVID-19: an update.
    Adir Y; Saliba W; Beurnier A; Humbert M
    Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34911694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE2 expression in allergic airway disease may decrease the risk and severity of COVID-19.
    Chhapola Shukla S
    Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2637-2640. PubMed ID: 33025046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
    Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
    Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.
    Shojaee A; Vahedian-Azimi A; Faizi F; Rahimi-Bashar F; Shahriary A; Galeh HEG; Nehrir B; Guest PC; Sahebkar A
    Adv Exp Med Biol; 2021; 1321():53-68. PubMed ID: 33656713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.
    Kai H; Kai M
    Hypertens Res; 2020 Jul; 43(7):648-654. PubMed ID: 32341442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
    Malek Mahdavi A
    Rev Med Virol; 2020 Sep; 30(5):e2119. PubMed ID: 32584474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19.
    Gao YD; Agache I; Akdis M; Nadeau K; Klimek L; Jutel M; Akdis CA
    Int Immunol; 2022 Mar; 34(4):177-188. PubMed ID: 34788827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus disease 2019 and severe asthma.
    Benfante A; Pirrello G; Sala F; Seminara G; Scichilone N
    Curr Opin Allergy Clin Immunol; 2023 Apr; 23(2):193-198. PubMed ID: 36752375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.
    Öztürk AB; Çağlayan B
    Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):282-285. PubMed ID: 32914945
    [No Abstract]   [Full Text] [Related]  

  • 20. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.
    Ren W; Zhu Y; Lan J; Chen H; Wang Y; Shi H; Feng F; Chen DY; Close B; Zhao X; Wu J; Tian B; Yuan Z; Zhou D; Saeed M; Wang X; Zhang R; Ding Q
    J Virol; 2022 Jan; 96(1):e0149221. PubMed ID: 34668773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.